LEPROSY
Leprosy Review
0305-7518
British Leprosy Relief Association
Colchester, UK
08-3086
0305-7518/18/064053+04
10.47276/lr.89.1.83
Case Report
Testicular atrophy and its clinical manifestations in a patient released from leprosy treatment
AchdiatPati Aji
aGunawanHendra
aSuwarsaOki
aa
Division of Bacterial and Parasitic Infection, Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung 40161, West Java, Indonesia
Correspondence to: Yola Fadilla and Hendra Gunawan, Division of Bacterial and Parasitic Infection, Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung 40161 Indonesia (Tel: +62222032426 ext. 3449; e-mail: fadillayola@gmail.com; endaguna@yahoo.com)
01032018
89
1
83
86
11022018
© Lepra
2018
Leprosy is a disease that results in various organ impairments, including testicular atrophy. Testicular damage in leprosy causes gynaecomastia, decreased libido, erectile dysfunction (impotence), altered distribution of pubic hair, and infertility. Until now, testicular screening in leprosy patients has not been given special attention by health workers, even by specialists. The aim of this report is to emphasize the importance of testicular screening in leprosy patients.
Leprosytesticular atrophygynaecomastia